Methods: Peptide Synthesis, VEGFR1D2 expression and purification, Table S1 : Calculated and experimental molecular weight of synthesized peptides (Table S1 ).
AcHx and AcHx(thioester) peptide synthesis.
Hx peptide (Fig. 3) was synthesized by Fmoc chemistry using the resin Rink Amide PEG-MBHA 200-400 mesh (0.54 mmol/g, Iris Biotech GmbH, Marktredwitz, Germany). kanamycin and 33 μg mL -1 chloramphenicol was grown in shaking flasks at 37 °C until reaching 0.7/0.8 OD 600 . Then, they were induced with 0.7 mM IPTG. After 4-5 h, the cells were harvested by centrifugation; the pellet was dissolved in 50 mM Tris-HCl, pH=8 containing protease inhibitors cocktail (Roche), to avoid proteins degradation, and the suspension was sonicated for 6 min, by using a Misonix Sonicator 3000 apparatus (Misomix, Farmingdale, US) with a micro tip probe and an impulse output of 1.5/2 (=9/12 Watt). Bacterial lysate was then centrifuged (17000 rpm, 30 min, 4°C) and the supernatant (soluble fraction) and the pellet samples were analyzed by SDS-PAGE.
The inclusion body pellet was solubilized in 50 mM Tris-HCl, 10 mM imidazole, 8M urea, pH 8.
For purification of VEGFR1D2 , solubilized protein was applied on Ni 2+ -NTA resin (45 min, 20°C) in the presence of 300 mM NaCl. The His-tagged protein was refolded by equilibrating the resin in 50 mM Tris-HCl, 10 mM imidazole, 300 mM NaCl, pH 8 with decreasing concentrations of urea and then it was eluted with increasing imidazole concentration from 100 to 300 mM. The 15 Nlabeled recombinant VEGFR1D2 2 was prepared according to Sambrook et al. 3 adding to the medium 15 NH 4 Cl as the unique source of nitrogen. The expression, refolding, and protein purification were performed as described for the unlabeled protein. Refolded VEGFR1D2 was dialyzed overnight in 50 mM Tris-HCl, pH 7.0, and NaCl 250 mM at 4 °C.
The cleavage of the His-tagged protein (labeled and unlabeled) was performed in presence of Glutathione (3 mM reduced/ 0.3 mM oxidized) for 3 h at 30 °C, adding TEV protease to protein substrate in a molar ratio (protease:substrate) of 1:35. Finally, VEGFR1D2 was purified to homogeneity by size exclusion chromatography using a S75 column (GE Healthcare) equilibrated in 50 mM Tris-HCl and 150 mM NaCl, pH 7. Finally, it was concentrated until 0.9 mM by the Amicon Ultra system (10.000 MWCO, Millipore) and identified by LC-MS 2 . Figure S3 . LC-MS analyses of purified EP0 -EP6 peptides. HPLC chromatograms were revealed at 210 nm. The mass spectrum of the indicated HPLC peak is shown in the inset. 
EP5
Time ( Figure S4 . In vitro angiogenic properties of EP6 and AcHx peptides. HUVEC were plated onto a layer of basement membrane matrix (Matrigel) and incubated at 37 °C for 18 h in the presence of EP6 (50 ng/ml) and AcHx (50 or 26 ng/ml). After treatment, tubular structures and photomicrographs were quantified as angiogenic index, calculated as the number of complete circles counted/field by microscope image analysis (Bottom). *p<0.05 vs control. 
